Loading…
Sandu Pharmaceuticals (BSE 524703)₹36.72−0.62%Pharmaceuticals
At the end of the Jun 2026 quarter, Sandu Pharmaceuticals' shareholders were: promoters 37.80%, DIIs 0.01%, public 62.19%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 10,266 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 42.92% | 42.92% | 42.92% | 42.92% | 42.92% | 42.92% | 42.92% | 42.92% | 42.92% | 37.80% | 37.80% | 37.80% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 57.07% | 57.07% | 57.07% | 57.07% | 57.07% | 57.07% | 57.07% | 57.07% | 57.07% | 62.19% | 62.19% | 62.19% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 10,101 | 10,019 | 9,999 | 10,010 | 10,244 | 10,331 | 10,285 | 10,224 | 10,282 | 10,282 | 10,296 | 10,266 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Umesh Bhaskar Sandu | Promoter | 14.40% | 0.00 |
| Shashank Bhaskar Sandu | Promoter | 14.18% | 0.00 |
| Jayshree Bhaskar Sandu | Promoter | 7.59% | 0.00 |
| Sanmark Realty And Finance Private Limited | Public | 5.57% | 0.00 |
| Akshath Finvest And Properties Private Limited | Public | 5.16% | 0.00 |
| Neelamber Leasing And Finvest Private Limited | Public | 4.72% | 0.00 |
| Tanvi Jignesh Mehta | Public | 4.57% | −0.05 |
| Sanbro Marketing Services Pvt Ltd | Public | 2.58% | 0.00 |
| Noumura Realty And Constructions Private Limited | Public | 2.26% | 0.00 |
| Phybrichem Engineers Private Limited | Public | 1.60% | 0.00 |
| Hitesh Kuvelkar | Public | 1.25% | 0.00 |
| Geeta U Sandu | Promoter | 0.88% | 0.00 |
| Minal Shashank Sandu | Promoter | 0.64% | 0.00 |
| Shubhada Prabhakar Sandu | Promoter | 0.10% | 0.00 |
Promoters held 37.80% of Sandu Pharmaceuticals at the end of the Jun 2026 quarter, down 5.12 percentage points from 42.92% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.01% (unchanged at 0.01% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Sandu Pharmaceuticals had 10,266 shareholders at the end of the Jun 2026 quarter, against 10,224 a year earlier.
Sanmark Realty And Finance Private Limited (Public) held 5.57% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.